A large TriNetX cohort of almost 548,000 matched patients showed that, at 12 months, GLP-1 users had a raised risk not only of telogen effluvium but also of androgenetic alopecia (around 1.6-fold)
As research continues, these drugs are not just reshaping waistlines but redefining obesity treatment at its biological roots
Most recently, she served as director of the Center for Student Diversity at Towson University in Maryland
Schedule an appointment today with Jarred Mait, MD, one of Miamis top concierge doctors.
Answer 6 questions and the tool shows you what patients with similar goals are running: which peptides they use, typical dosing, injection schedule, reconstitution steps, cycle length, and when they pause
Technically, retatrutide begins working shortly after administration